Cancer BiologybioRxivPreprint
The H3K36M oncohistone inhibits NSD2 to activate a SETD2-dependent antiviral-like immune response in KRAS-driven lung cancer
Amy C. Gladstein, Carson D. Poltorack, Charles Solomon Akino Mercy…·David M. Feldser
The paper shows that H3K36M oncohistone inhibits NSD2, leading to SETD2-dependent antiviral immune response and tumor clearance in KRAS-driven lung cancer.
2 citations